[Improved survival in patients with NET of the pancreas with molecular therapies]. | Z Gastroenterol;49(11): 1489-90, 2011 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

[Improved survival in patients with NET of the pancreas with molecular therapies]. / Verbesserung des mittleren Überlebens von Patienten mit neuroendokrinen Karzinomen des Pankreas durch die Behandlung mit molekularen Therapien.

Greten, T F.

Affiliation

Greten TF; National Institutes of Health, National Cancer Institute, Building 10 Rm 12N226, 9000 Rockville Pike, Bethesda, MD 20892, USA. tim.greten@nih.gov

Z Gastroenterol ; 49(11): 1489-90, 2011 Nov.

Article in De | MEDLINE | ID: mdl-22069050

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: De Journal: Z Gastroenterol Year: 2011 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: De Journal: Z Gastroenterol Year: 2011 Document type: Article Affiliation country: